ema prac naion semaglutide june 2025 warns Ozempic linked to 'very rare' side effect FDA Sends Warning Letter to

GLP-1 receptor agonists like semaglutide act on brain centers that control hunger, satiety, and food preferencenot just appetite suppression

In line with these data, the GLP-1R has been found to be co-expressed in ARC POMC neurons in both rats (Sandoval et al., 2008) and mice (Ronnekleiv et al., 2014) suggesting that GLP-1 can act directly on these neurons

In other words: yes, were closer than ever to brain-health breakthroughs

People with normal baseline glucose levels who use semaglutide for weight loss typically experience modest improvements in insulin sensitivity and fasting glucose, even when starting values are already healthy

These medications have had a significant impact on weight loss

Following the semi qualitative assessment, the ROS levels were quantified by flow cytometry